As the principal and managing director of Chrysoli, Damian has decades of experience in market access, reimbursement and HEOR leadership, strategy and execution. His diverse experience has been leveraged as both a medical affairs expert and commercial leader, thus understands well how to compliantly bridge strategies between both disciplines within organizations.
His experience includes small molecule pharma, large molecule pharma, biopharmaceuticals, medical devices and “consumercueticals”. This includes working for Pfizer, Johnson & Johnson, Medtronic, and Acadia Pharmaceuticals in many disciplines including HEOR, Market Access, Healthcare Policy, Reimbursement and Operations.
Publications
Neurology
Characteristics, Conditions, and Healthcare Service Utilization Patterns of Individuals Diagnosed with Rett Syndrome: An Analysis of Administrative Claims Data
Characterizing the journey of Rett syndrome among females in the United States: a real-world evidence study using the Rett syndrome natural history study database
Clinical Management of Rett Syndrome in the Real World: A Physician Survey (P12-4.002)
Epidemiology and patient journey of Rett syndrome in the United States: a real-world evidence study
Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson’s Disease: A PMD Alliance Survey
Gastrointestinal manifestations in pediatric and adult patients with Rett syndrome: an analysis of US claims and physician survey data
Real-world clinical management of individuals with Rett syndrome: a physician survey
Role of Pimavanserin Treatment-Continuity on Discharge From Long-term Care: Assessing the Quality of Antipsychotic Medication Review
Understanding Characteristics, Conditions and Treatment Patterns among Males Diagnosed with Rett Syndrome: An Analysis of Commercial Health Insurance Claims
Cardiology
Adherence to heart failure management medications following cardiac resynchronization therapy
Cost-effectiveness analysis of implantable cardiac devices in patients with systolic heart failure: a US perspective using real world data
Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device
Cost-Effectiveness of Thoracotomy Approach for the Implantation of a Centrifugal Left Ventricular Assist Device


